AdaptHealth (AHCO) Total Debt Growth (3y) (2021 - 2026)
AdaptHealth (AHCO) Total Debt Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 0.11% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -0.32% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 5.42% |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.61% |
| 10 | AdaptHealth | 1.49 Bn | 1.45 Bn | 111.50 Mn | -6.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.76% |
| Dec 31, 2025 | -7.91% |
| Sep 30, 2025 | -6.77% |
| Jun 30, 2025 | -5.98% |
| Mar 31, 2025 | -3.82% |
| Dec 31, 2024 | -3.51% |
| Sep 30, 2024 | -2.50% |
| Jun 30, 2024 | 4.22% |
| Mar 31, 2024 | 7.58% |
| Dec 31, 2023 | 39.89% |
| Sep 30, 2023 | 44.51% |
| Jun 30, 2023 | 70.65% |
| Mar 31, 2023 | 68.98% |
| Dec 31, 2022 | 77.61% |
| Mar 31, 2022 | 143.76% |
| Dec 31, 2021 | 154.95% |